Patent · US Active

Oxazolidin-2-one compounds and uses thereof

US8865894B2 · kind B2 · utility

7Cited by

26References

22Claims

0Family size

Assignee

Novartis AG · CH

Inventors

Giorgio Caravatti · Allschwil, CH
Robin Alec Fairhurst · Riehen, CH
Pascal Furet · Basel, CH
Frederic Stauffer · Hésingue, FR
Frank Hans Seiler · Glückstadt, DE
Clive McCarthy · Woodstock, GB
Heinrich Rueeger · Interlaken, CH

Key dates

Filing date	Feb 22, 2013
Grant date	Oct 21, 2014
Priority date	—
Expiry date	Feb 22, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/14
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to oxazolidin-2-one substituted pyrimidine compounds that act as PI3K (phosphatidylinositol-3-kinase) inhibitors, as well as pharmaceutical compositions thereof, methods for their manufacture and uses for the treatment of conditions, diseases and disorders dependent on PI3K.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.